Intrinsiqs

Is Spyre Therapeutics, Inc. overvalued?

Spyre Therapeutics, Inc. (SYRE) — key valuation metrics and fundamentals.

No verdict
Price
$89.95
Fair value
Current P/E
Normal P/E
Market cap
$5.30B
Dividend yield
Return on equity
Sector
Healthcare

See the full interactive analysis →

Fair value compares SYRE's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 29 Jun 2026.